Sanjin Zvonic is a cell and molecular biologist with a strong technical/scientific background in physiology, stem cell biology, and cell therapy CMC development. Zvonic has held roles at PCT and Novartis’ Cell and Gene Therapy Unit, most recently serving as vice president of product development and manufacturing at WindMIL Therapeutics. In his current role at Dark Horse Consulting, he is focused on strategic growth and development of the BD function, client engagement, and pipeline growth, while continuing to leverage his technical background as a practice expert on select projects.

After earning his doctorate in Cell and Molecular Biology, Zvonic continued on to a post-doctoral position at the Pennington Biomedical Research Center, followed by a second post-doctoral role at Tulane University.